Quantification of myocardial blood flow with 82Rb dynamic PET imaging

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 11, 2007, Pages 1765-1774

  Lortie, Mireille ^a   Beanlands, Rob S B ^a   Yoshinaga, Keiichiro ^a   Klein, Ran ^a   DaSilva, Jean N ^a   DeKemp, Robert A ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Myocardial blood flow; Perfusion; PET; Rubidium 82; Tracer kinetic modeling

Indexed keywords

AMINOPHYLLINE; AMMONIA N 13; DIPYRIDAMOLE; RUBIDIUM 82;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART HEMODYNAMICS; HEART MUSCLE BLOOD FLOW; HEART RATE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; BLOOD FLOW VELOCITY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; CORONARY VESSELS; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RUBIDIUM RADIOISOTOPES;

EID: 34249701087     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0478-2     Document Type: Article

References (57)

1. Tamaki N, Ruddy TD, deKemp R, Beanlands RSB. Myocardial Perfusion. In: Wahl RL, editor. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins; 2002; p. 320-33.
2. Herrero P, Markham J, Shelton ME, Weinheimer CJ, Bergmann SR. Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography: exploration of a mathematical model. Circulation 1990;82:1377-86.
3. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med 1996;37:1701-12.
4. 82Rb kinetics and a compartmental model for blood flow estimation. Am J Physiol 1989;256:H1156-64.
5. Herrero P, Markham J, Shelton ME, Bergmann SR. Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. Circ Res 1992;70:496-507.
6. Coxson PG, Huesman RH, Borland L. Consequences of using a simplified kinetic model for dynamic PET data. J Nucl Med 1997;38:660-7.
7. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-8.
8. 13N]ammonia via proton irradiation of dilute aqueous ethanol and acetic acid mixtures. Appl Radiat Isot 1991;42:1095-8.
9. Alvarez-Diez TM, deKemp R, Beanlands R, Vincent J. Manufacture of strontium-82/rubidium-82 generators and quality control of rubidium-82 chloride for myocardial perfusion imaging in patients using positron emission tomography. Appl Radiat Isot 1999;50:1015-23.
10. Townsend DW, Beyer T, Jerin J, Watson CC, Young J, Nutt R. The ECAT ART scanner for positron emission tomography. 1. Improvements in performance characteristics. Clin Positron Imaging 1999;2:5-15.
11. 82Rb infusion system for quantitative perfusion imaging with 3D PET. Appl Radiat Isotopes 2004;60:921-7.
12. 82Rb generator for cardiac perfusion imaging with positron emission tomography. Phys Med Biol 2007;52:659-73.
13. ICRP Publication 80. Radiation dose to patients from radiopharmaceuticals. New York: Pergamon; 2001.
14. Watson CC, Newport D, Casey ME, deKemp RA, Beanlands RSSM. Evaluation of simulation-based scatter correction for 3-D PET cardiac imaging. IEEE Trans Nucl Sci 1997;44:90-7.
15. Watson CC. New, faster, image-based scatter correction of 3D PET. IEEE Trans Nucl Sci 2000;47:1587-94.
16. 15 O and 3-dimensional PET: an experimental validation. J Nucl Med 2002;43:1031-40.
17. deKemp RA, Nahmias C. Automated determination of the left ventricular long axis in cardiac positron tomography. Physiol Meas 1996;17:95-108.
18. Laubenbacher C, Rothley J, Sitomer J, Beanlands R, Sawada S, Sutor R, et al. An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. J Nucl Med 1993;34:968-78.
19. Weinberg IN, Huang SC, Hoffman EJ, Araujo L, Nienaber C, Grover-McKay M, et al. Validation of PET-acquired input functions for cardiac studies. J Nucl Med 1988;29:241-7.
20. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-42.
21. 11C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med 2001;42:1174-82.
22. Coxson PG, Brennan KM, Huesman RH, Lim S, Budinger TF. Variability and reproducibility of rubidium-82 kinetic parameters in the myocardium of the anesthetized canine. J Nucl Med 1995;36:287-96.
23. 82Rb kinetic parameter estimates: computer simulations and dynamic PET studies. Proceedings of the 22nd Annual International Conference of the IEEE Engineering and Medicine in Biology Society 2000;2:1096-9.
24. Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med 1992;33:1243-50.
25. Muzik O, Beanlands RSB, Hutchins GD, Mangner TJ, Nguyen N, Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 1993;34:83-91.
26. Trust region methods for nonlinear minimization. Optimization toolbox user's guide. The mathworks; 2000; p. 3.3-3.5.
27. Landaw EM, DiStefano JJ. Multiexponential, multicompartmental, and noncompartmental modeling. II. Data analysis and statistical considerations. Am J Physiol 1984;246:R665-77.
28. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959;197:1205-10.
29. Crone C. Permeability of capillaries in various organs as determined by use of the indicator diffusion method. Acta Physiol Scand 1963;58:292-305.
30. Kanji GK. 100 Statistical tests. Newbury Park, CA: SAGE Publications; 1993.
31. Fitting Data. Curve fitting toolbox user's guide. The mathworks; 2002; p. 3.1-3.76.
32. Muzik O, Beanlands R, Wolfe E, Hutchins GD, Schwaiger M. Automated region definition for cardiac nitrogen-13-ammonia PET imaging. J Nucl Med 1993;34:336-44.
33. Beanlands RS, Muzik O, Melon P, Sutor R, Sawada S, Muller D, et al. Noninvasive quantification of regional myocardial flow reserve in patients with coronary atherosclerosis using nitrogen-13 ammonia positron emission tomography. Determination of extent of altered vascular reactivity. J Am Coll Cardiol 1995;26:1465-75.
34. Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-86.
35. Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;88:62-9.
36. Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krivokapich J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992;20:979-85.
37. Gewirtz H, Skopicki HA, Abraham SA, Castano H, Dinsmore RE, Alpert NM, et al. Quantitative PET measurements of regional myocardial blood flow: observations in humans with ischemic heart disease. Cardiology 1997;88:62-70.
38. Yoshinaga K, Chow BJW, deKemp RA, Thorn S, Ruddy TD, Davies RA, et al. Application of cardiac molecular imaging using positron emission tomography in evaluation of drug and therapeutics for cardiovascular disorders. Curr Pharm Des 2005;11:903-32.
39. Schelbert HR, Phelps ME, Huang S-C, MacDonald NS, Hansen H, Selin C, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259-72.
40. Nagamachi S, Czernin J, Kim AS, Sun KT, Böttcher M, Phelps ME, et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 1996;37:1626-30.
41. Camici PG. Positron emission tomography and myocardial imaging. Heart 2000;83:475-80.
42. Uren NG, Melin JA, De Bruyne B, Wijns W, Baudhuin T, Camici PG. Relation betwen myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994;330:1782-8.
43. Guethlin M, Kasel AM, Coppenrath K, Ziegler S, Delius W, Schwaiger M. Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Circulation 1999;99:475-81.
44. De Bruyne B, Baudhuin T, Melin JA, Pijls NH, Sys SU, Bol A, et al. Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. Circulation 1994;89:1013-22.
45. Goldstein RA. Kinetics of rubidium-82 after coronary occlusion and reperfusion. Assessment of patency and viability in open-chested dogs. J Clin Invest 1985;75:1131-7.
46. Goldstein RA. Rubidium-82 kinetics after coronary occlusion: Temporal relation of net myocardial accumulation and viability in open-chested dogs. J Nucl Med 1986;1456-61.
47. Gould KL, Yoshida K, Hess MJ, Haynie M, Mullani N, Smalling RW. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. J Nucl Med 1991;32:1-9.
48. vom Dahl J, Muzik O, Wolfe ERJ, Allman C, Hutchins G, Schwaiger M. Myocardial rubidium-82 tissue kinetics assessed by dynamic positron emission tomography as a marker of myocardial cell membrane integrity and viability. Circulation 1996;93:238-45.
49. Schelbert H. Positron emission tomography of the heart: methodology, findings in the normal and the diseased heart, and clinical applications. In: Phelps ME, editor. PET molecular imaging and its biological applications. Berlin Heidelberg New York: Springer; 2004; p. 389-508.
50. Glatting G, Bergmann KP, Stollfuss JC, Weismueller P, Kochs M, Hombach V, et al. Myocardial Rb extraction fraction: determination in humans. J Am Coll Cardiol 1995;25:364A-5A.
51. 82Rb and wavelet-based noise reduction. J Nucl Med 2001;42:201-8.
52. Goldstein RA, Mullani NA, Marani SK, Fisher DJ, Gould KL, O'Brien HA. Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. J Nucl Med 1983;24:907-15.
53. 86Rb after temporary coronary occlusion. Am J Physiol 1978;234:H724-9.
54. Mullani NA, Goldstein RA, Gould KL, Marani SK, Fisher DJ, O'Brien HA, et al. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med 1983;24:898-906.
55. Villanueva FS, Smith WH, Watson DD, Beller GA. ST-segment depression during dipyridamole infusion, and its clinical, scintigraphic and hemodynamic correlates. Am J Cardiol 1992;69:445-8.
56. Bacharach SL, Bax JJ, Case J, Delbeke D, Kurdziel KA, Martin WH, et al. PET myocardial glucose metabolism and perfusion imaging: guidelines for patient preparation and data acquisition. J Nucl Cardiol 2003;10:543-54.
57. Schelbert HR, Beanlands R, Bengel F, Knuuti J, DiCarli M, Machac J, et al. PET myocardial glucose metabolism and perfusion imaging: guidelines for interpretation and reporting. J Nucl Cardiol 2003;10:557-71.